Announcements Trials
Browse Landscape

Phase

Phase 1 9Phase NA 5Phase 2 5Phase EARLY_PHASE1 3Phase 2/3 3Phase 4 1Phase 1/2 1

Status

Recruiting 3

Sponsor Class

OTHER_GOV 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Pancreatic Neoplasms 1Liver Metastases 1Disease 1Colonic Neoplasms 1

Interventions

Cisplatin 30Magnetic Resonance Spectroscopy 23Carboplatin 23pembrolizumab 21Paclitaxel 20Gemcitabine 19Specimen Handling 16Drug Therapy 15Dexamethasone 15Radiotherapy 14Nivolumab 14Doxorubicin 14Bevacizumab 14atezolizumab 13Oxaliplatin 13Cyclophosphamide 13Radiation 11Pemetrexed 11Cytarabine 11venetoclax 10Vincristine 10Prednisone 10Docetaxel 10Capecitabine 10Trastuzumab 9Temozolomide 8Rituximab 8Platinum 8Ipilimumab 8Fluorouracil 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × Positron Emission Tomography Computed Tomography × 1 year × Clear all
NCT04143516 2026-03-19

Tissue Analysis After Tumor Ablation for Liver Metastases Leading to Immediate Retreatment

Memorial Sloan Kettering Cancer Center

Phase 2/3 Recruiting
200 enrolled

Liver Metastases

NCT07272772 2025-12-09

Colon Cancer Diagnosis With FAPI-PET Imaging

Turku University Hospital

Phase 2/3 Recruiting
100 enrolled
Gastrointestinal

Colonic Neoplasms

NCT07098598 2025-08-01

Pancreatic Cancer Diagnosis With FAPI-PET Imaging

Turku University Hospital

Phase 2/3 Recruiting
100 enrolled
Gastrointestinal

Disease, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡